Westside Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48K | Hold |
500
| – | – | ﹤0.01% | 1159 |
|
|
2025
Q1 | $3.75K | Hold |
500
| – | – | ﹤0.01% | 820 |
|
|
2024
Q4 | $3.76K | Hold |
500
| – | – | ﹤0.01% | 814 |
|
|
2024
Q3 | $3.8K | Hold |
500
| – | – | ﹤0.01% | 814 |
|
|
2024
Q2 | $3.09K | Hold |
500
| – | – | ﹤0.01% | 832 |
|
|
2024
Q1 | $2.54K | Hold |
500
| – | – | ﹤0.01% | 809 |
|
|
2023
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 760 |
|
|
2023
Q3 | $3.54K | Hold |
500
| – | – | ﹤0.01% | 730 |
|
|
2023
Q2 | $3.52K | Buy |
+500
| New | +$3.52K | ﹤0.01% | 737 |
|